1-2 of 2
Ikuyo Ota Tsutsumi, MD
Close
Sort by
Journal Articles

Efficacy and Safety of Once-Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CBD) Regimen As Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma. -a Phase 2 Multicenter Trial-

Daisuke Kudo, MD, Takuya Komeno, MD MPH, PhD, Chikashi Yoshida, MD PhD, Ikuyo Ota Tsutsumi, MD, Kazuteru Ohashi, MD PhD, Kazuhiko Kakihana, MD PhD, Takeshi Kobayashi, MD, Noriko Doki, MD PhD, Yuho Najima, MD, Aiko Igarashi, MD, Mitsuo Hori, MD PhD, Yasushi Okoshi, MD PhD, Takayuki Fujio, MD, Atsushi Shinagawa, MD PhD, Masahide Yamamoto, MD PhD, Hina Takano, MD PhD, Takashi Kumagai, MD PhD, Koh Yamamoto, MD PhD, Shigeo Toyota, MD PhD, Yuichi Nakamura, MD PhD, Hiroshi Kojima, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2160.
https://doi.org/10.1182/blood-2018-99-113788
Published: 2018
Journal Articles

Impact of Oral Voriconazole As Prophylaxis during Intensive Chemotherapy for Adult Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study Using Japanese Administrative Database

Ikuyo Ota Tsutsumi, MD, Chikashi Yoshida, MD PhD, Masanori Seki, MD PhD, Takuya Komeno, MD MPH, PhD, Susumu Kunisawa, MD PhD, Kiyohide Fushimi, MD PhD, Yuichi Imanaka, MD DrMedSc, PhD MPH
Journal: Blood
Blood (2017) 130 (Supplement 1): 3371.
https://doi.org/10.1182/blood.V130.Suppl_1.3371.3371
Published: 2017